Article
CRISPR interference identifies vulnerable cellular pathways with bactericidal phenotypes in Mycobacterium tuberculosis.
Molecular microbiology - 1 Oct 2021
McNeil Matthew B, Keighley Laura M, Cook Josephine R, Cheung Chen-Yi, Cook Gregory M
Abstract excerpt
Mycobacterium tuberculosis remains a leading cause of death for which new drugs are needed. The identification of drug targets has been advanced by high-throughput and targeted genetic deletion strategies. Each though has limitations including the inability to distinguish between levels of vulnerability, lethality, and scalability as a molecular tool. Using mycobacterial CRISPR interference in combination with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
